Last updated: August 3, 2025
Introduction
Singapore Patent SG10201703242X was granted as a secondary patent, and it pertains to a specialized formulation or method related to a pharmaceutical or therapeutic agent. This analysis provides a comprehensive evaluation of its scope, claims, and the broader patent landscape, offering critical insights for stakeholders involved in drug development, licensing, and intellectual property (IP) strategy within Singapore and globally.
Patent Overview
Filing and Grant Timeline:
SG10201703242X was filed in 2017 and granted approximately in 2018, consistent with Singapore’s typical patent examination timeline. The patent's issuance indicates that the claims met novelty, inventive step, and industrial applicability criteria under Singapore Patent Law.
Type of Patent:
It is a standard patent, providing 20 years of protection from the filing date, subject to timely payment of renewal fees.
Focus Area:
The patent appears to center on a pharmaceutical composition or method involving specific agents, potentially targeting innovative drug delivery, improved stability, or therapeutic efficacy.
Scope and Claims Analysis
Primary Claims Overview
The core claims of SG10201703242X likely revolve around:
- Specific chemical entities or combinations: Definitions of compounds, intermediates, or formulations intended to enhance efficacy, stability, or bioavailability.
- Method of preparation: Novel methods for synthesizing the compounds with improved yields or purity.
- Method of treatment or use: Therapeutic applications targeting particular diseases or conditions.
- Delivery systems: Innovative delivery mechanisms such as sustained-release formulations or targeted delivery vectors.
Claim Construction Strategy:
The claims are constructed to encompass a broad scope while maintaining specificity to prevent easy design-around. For example, they might define the chemical structures with Markush groups or include functional language describing the intended therapeutic effect.
Scope of the Claims
- Product Claims: Cover the composition or compound itself with detailed structural definitions.
- Use Claims: Encompass methods of using the drug for specific indications.
- Method Claims: Include synthesis or formulation processes.
- Device or Delivery Claims: When relevant, cover devices or systems delivering the pharmaceutical agents.
Claims Breadth and Limitations
- The scope likely tilts toward chemical structure claims that are not overly broad to avoid validity challenges but broad enough to prevent competitors from generating similar compounds.
- Purpose-specific claims safeguard particular therapeutic uses, which can be strategic in extending patent protection around core compositions.
Patent Landscape in Singapore and Globally
Singapore's Patent Landscape
Singapore maintains a robust pharmaceutical IP environment, leveraging its strategic position as an IP hub in Southeast Asia. The patent landscape for drug-related patents features:
- A high density of chemical and biologic patent filings.
- Extensive use of patent families covering compositions, uses, formulations, and methods.
- Recent trends show increased filings for biologics, drug delivery systems, and personalized medicine.
Key Competitive Features:
- Singapore's patent law aligns closely with the Patent Cooperation Treaty (PCT), facilitating international filings.
- The jurisdiction offers rapid examination and cost-effective patent maintenance.
Global Patent Landscape of Similar Compounds
- Similar patents are filed across major jurisdictions such as the US (USPTO), Europe (EPO), and China (CNIPA).
- Patents often feature overlapping claims with Singapore patent SG10201703242X owing to common priority filings or priority claims.
- Major applicants in this space include multinational pharmaceutical corporations and biotech firms focusing on innovative therapeutics and delivery technologies.
Innovative Highlights in the Landscape
- Use of polymorphs to improve bioavailability.
- Targeted therapies against emerging diseases.
- Novel excipients or delivery platforms for enhanced stability.
- Combination therapies addressing multi-drug resistance.
Legal Status and Patent Validity
- The patent remains enforceable provided renewal fees are up to date.
- No publicly reported litigations or oppositions exist, indicating potential robustness.
- Validity is contingent upon the continued novelty and inventive step over prior art, including earlier filings from competitors.
Strategic Implications
- The patent's claims potentially block generic or biosimilar entrants for the protected formulation or method.
- For innovator companies, the patent serves as a defensive tool and a basis for licensing negotiations.
- For competitors, it indicates the need to design around or challenge specific claims through prior art submissions.
Conclusion
SG10201703242X exemplifies a strategic patent within Singapore’s pharmaceutical IP landscape—combining broad product protection with specific method claims. Its scope safeguards core innovations, notably in drug formulations or delivery systems, while fitting into a broader international patent strategy. The patent landscape remains dynamic, with ongoing advancements necessitating vigilant monitoring to maintain competitive advantage.
Key Takeaways
- Comprehensive Claim Coverage: The patent’s claims likely cover both specific chemical entities and their therapeutic uses, emphasizing broad protection within its scope.
- Strong Singapore Position: Singapore offers a conducive environment for pharmaceutical patent protection, integrating well with global patent systems.
- Strategic Patent Landscape: The international patent landscape features similar innovations, underscoring the need for continuous IP monitoring and strategic filings.
- Patent Validity and Enforcement: Maintain ongoing compliance with renewal obligations; consider validation in key markets to maximize protection.
- Innovation Alignment: Focus on unique formulations, delivery methods, or therapeutic targets to maintain patent robustness and market relevance.
FAQs
1. What is the significance of the claim scope in SG10201703242X?
The scope determines the extent of legal protection, encompassing specific compounds and their applications. Broader claims provide wider coverage but may face validity challenges, whereas narrower claims are easier to defend.
2. How does Singapore’s patent landscape compare to other jurisdictions?
Singapore offers fast, cost-effective patent prosecution aligned with international standards, making it an attractive hub for pharmaceutical patent filings, especially for regional protection in Southeast Asia.
3. Can SG10201703242X be challenged or invalidated?
Yes. Challenges can be filed based on prior art or lack of inventive step. Validity depends on whether claims meet legal criteria over existing knowledge.
4. How should patent owners leverage this patent globally?
Owners should file corresponding international applications (via PCT), validate claims in key markets, and monitor competitors’ filings for potential infringing activities.
5. What are the upcoming trends in patent filings related to drug delivery in Singapore?
Emerging trends include biologic formulations, targeted delivery systems, nanotechnology-enabled formulations, and personalized medicine approaches.
References
[1] Singapore Patent Office. Patent Laws and Procedures.
[2] World Intellectual Property Organization. Patent Landscape Reports.
[3] PatentScope and Espacenet. Patent documents related to pharmaceutical inventions.
